| Source NDC Code |
|
Target HCPCS Code |
72903-0853-01
ELAHERE 100 MG/20 ML VIAL
|
⇄
|
C9146
Injection, mirvetuximab soravtansine-gynx, 1 mg
|
| Detail Information |
| Relationship Start Date |
04/01/2023 |
| Relationship End Date |
06/30/2023 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
72903-0853-01
ELAHERE (SDV,PF,LATEX-FREE) 5 MG/1 ML
|
⇄
|
J9063
INJECTION, MIRVETUXIMAB SORAVTANSINE-GYNX, 1 MG
|
| Detail Information |
| Relationship Start Date |
07/01/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
|
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
72903-0853-01
ELAHERE 100 MG/20 ML VIAL
|
⇄
|
J9999
NOT OTHERWISE CLASSIFIED, ANTINEOPLASTIC DRUGS
|
| Detail Information |
| Relationship Start Date |
04/01/2023 |
| Relationship End Date |
06/30/2023 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
72903-0853-01
ELAHERE
|
⇄
|
J9063
Inj, elahere, 1 mg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|